Christoph Driessen

Christoph Driessen

UNVERIFIED PROFILE

Are you Christoph Driessen?   Register this Author

Register author
Christoph Driessen

Christoph Driessen

Publications by authors named "Christoph Driessen"

Are you Christoph Driessen?   Register this Author

81Publications

2174Reads

41Profile Views

HIV protease inhibitors for the treatment of multiple myeloma.

Clin Adv Hematol Oncol 2019 Nov;17(11):615-623

Department of Medical Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland.

View Article

Download full-text PDF

Source
November 2019

Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.

Biochim Biophys Acta Mol Basis Dis 2019 06 4;1865(6):1666-1676. Epub 2019 Apr 4.

University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken, Translational Oncology, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2019.04.003DOI Listing
June 2019

Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer.

Cancer Chemother Pharmacol 2019 04 25;83(4):763-774. Epub 2019 Jan 25.

Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03783-9DOI Listing
April 2019

Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors.

Cell Chem Biol 2019 03 3;26(3):340-351.e3. Epub 2019 Jan 3.

Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. gallen, Rorschacher Strasse 95, St. Gallen 9007, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chembiol.2018.11.007DOI Listing
March 2019

Management of cardiovascular risk in patients with multiple myeloma.

Blood Cancer J 2019 02 26;9(3):26. Epub 2019 Feb 26.

Hematology Service, University Hospital Salamanca, Casa del Bedel, Cardenal Pla y Deniel, 22, Planta Baja, Salamanca, 37008, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-019-0183-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391463PMC
February 2019

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors.

Eur J Cancer 2019 Jan 7;107:8-14. Epub 2018 Dec 7.

Department of Dermatology, University Hospital of Zürich, CH-8091, Zürich, Switzerland; Institute of Immunobiology, Kantonsspital St.Gallen, CH-9007, St. Gallen, Switzerland; Department of Oncology and Hematology, Kantonsspital St. Gallen, CH-9007, St. Gallen, Switzerland; Department of Dermatology, Kantonsspital St. Gallen, CH-9007, St. Gallen, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183147
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.009DOI Listing
January 2019

Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab.

Hematol Oncol 2018 Oct 3;36(4):713-714. Epub 2018 Aug 3.

Department of Oncology/Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2533DOI Listing
October 2018

An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors.

Blood Adv 2018 10;2(19):2443-2451

Department of Medicine and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018016360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177641PMC
October 2018

Improved survival of older patients with multiple myeloma in the era of novel agents.

Hematol Oncol 2016 Dec 21;34(4):217-223. Epub 2015 Apr 21.

Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2205DOI Listing
December 2016

Multiple myeloma: practice patterns across Europe.

Br J Haematol 2016 10 13;175(1):66-76. Epub 2016 Jun 13.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14193DOI Listing
October 2016

Multiple myeloma: patient outcomes in real-world practice.

Br J Haematol 2016 Oct 13;175(2):252-264. Epub 2016 Jul 13.

'Seràgnoli' Institute of Hematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096152PMC
October 2016

Development of new Malt1 inhibitors and probes.

Bioorg Med Chem 2016 08 28;24(15):3312-29. Epub 2016 Mar 28.

Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2300 RA Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2016.03.035DOI Listing
August 2016

Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes.

J Med Chem 2016 08 1;59(15):7177-87. Epub 2016 Aug 1.

Gorlaeus Laboratories, Leiden Institute of Chemistry , Einsteinweg 55, 2333 CC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.6b00705DOI Listing
August 2016

A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities.

Angew Chem Int Ed Engl 2016 Mar 29;55(13):4199-203. Epub 2015 Oct 29.

Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.201509092DOI Listing
March 2016

The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells.

Haematologica 2015 Oct 11;100(10):1350-60. Epub 2015 Jun 11.

Experimental Oncology and Hematology, Department of Oncology and Hematology, Kantonsspital St.Gallen, Switzerland Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre, the Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.109421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591768PMC
October 2015

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

J Clin Oncol 2015 Aug 6;33(23):2523-9. Epub 2015 Jul 6.

Christoph Mamot and Mario Bargetzi, Cantonal Hospital Aarau, Aarau; Dirk Klingbiel, Christine Biaggi, and Corinne Rusterholz, Swiss Group for Clinical Cancer Research Coordinating Center; Thomas Pabst, Inselspital Bern, Bern; Felicitas Hitz and Christoph Driessen, Cantonal Hospital St. Gallen, St. Gallen; Christoph Renner, Hirslanden Zürich; Thomas Hany, Magnetic Resonance Imaging Roentgen Zürich; Andrei Samarin, University Hospital Zürich, Zürich; Ulrich Mey, Cantonal Hospital Graubuenden, Chur; Miklos Pless, Cantonal Hospital Winterthur, Winterthur; Fatime Krasniqi and Stephan Dirnhofer, University Hospital of Basel, Basel; Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and Federica Gigli and Giovanni Martinelli, European Institute of Oncology Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.9846DOI Listing
August 2015

Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.

J Med Chem 2014 Jul 15;57(14):6197-209. Epub 2014 Jul 15.

Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre , Einsteinweg 55, 2333 CC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm500716sDOI Listing
July 2014

Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.

PLoS One 2013 17;8(9):e74415. Epub 2013 Sep 17.

Gene Regulation and Chromatin Group, MRC Clinical Sciences Centre, Imperial College London, London, United Kingdom ; Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0074415PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775786PMC
May 2014

Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.

Leuk Res 2014 Mar 25;38(3):383-92. Epub 2013 Dec 25.

Department of Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland; Department of Medicine II, University of Tübingen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.12.017DOI Listing
March 2014

Cathepsin S dominates autoantigen processing in human thymic dendritic cells.

J Autoimmun 2012 Jun 16;38(4):332-43. Epub 2012 Mar 16.

Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2012.02.003DOI Listing
June 2012

Cathepsin G is differentially expressed in primary human antigen-presenting cells.

Cell Immunol 2009 25;255(1-2):41-5. Epub 2008 Nov 25.

Hertie Institute for Clinical Brain Research, University of Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2008.10.001DOI Listing
March 2009

Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.

Eur J Immunol 2008 Sep;38(9):2401-11

Experimental Neuroimmunology, Department of General Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200838413DOI Listing
September 2008

Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.

Cancer 2008 Feb;112(3):659-70

Department of Medicine III (Hematology, Oncology, and Transfusion Medicine), Charité, Campus Benjamin Franklin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.23224
Publisher Site
http://dx.doi.org/10.1002/cncr.23224DOI Listing
February 2008

A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A.

Biochem Biophys Res Commun 2007 Dec 4;364(2):243-9. Epub 2007 Oct 4.

Medical and Natural Sciences Research Centre, University of Tübingen, Ob dem Himmelreich 7, 72074 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.09.114DOI Listing
December 2007

A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles.

FEBS J 2007 Jun 22;274(12):3138-49. Epub 2007 May 22.

Medical and Natural Sciences Research Centre, University of Tübingen, and Children's Hospital Department I, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1742-4658.2007.05846.xDOI Listing
June 2007

Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins.

J Leukoc Biol 2007 Apr 29;81(4):990-1001. Epub 2007 Jan 29.

Department of Medicine II, Institute for Cell Biology, and Medical and Natural Sciences Research Center, University of Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.1006600DOI Listing
April 2007

Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.

Biol Chem 2006 Oct-Nov;387(10-11):1503-11

Interfacultary Institute for Biochemistry, University of Tübingen, Medical and Natural Sciences Research Centre, Ob dem Himmelreich 7, D-72074 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2006.188DOI Listing
December 2006

Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.

J Inorg Biochem 2005 Jun;99(6):1384-9

Leiden Institute of Chemistry, Gorlaeus Laboratories,Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinorgbio.2005.03.014DOI Listing
June 2005

Modulation of the endosomal and lysosomal distribution of cathepsins B, L and S in human monocytes/macrophages.

Biol Chem 2002 Jul-Aug;383(7-8):1277-83

Institut für Pathologie, Universitätsklinikum Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2002.143DOI Listing
July 2003

Activity and subcellular distribution of cathepsins in primary human monocytes.

J Leukoc Biol 2003 Feb;73(2):235-42

Department of Medicine II, University of Tübingen, Ob dem Himmelreich 7, 72074 Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0802398DOI Listing
February 2003

Characterization of legumain.

Biol Chem 2002 Nov;383(11):1813-6

Institute of Physiological Chemistry, University of Tübingen, Ob dem Himmelreich 7, D-72074 Tübingen, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2002.203DOI Listing
November 2002

Specific role for cathepsin S in the generation of antigenic peptides in vivo.

Eur J Immunol 2002 02;32(2):467-76

Department of Pathology, Harvard Medical School, Armenise Building, 200 Longwood Avenue, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.christian-luber.de/pdf/2002/hk200210.pdf
Web Search
http://dx.doi.org/10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-YDOI Listing
February 2002